{
    "clinical_study": {
        "@rank": "127896", 
        "arm_group": {
            "arm_group_label": "Acute kidney injury", 
            "description": "ICU patients with Acute kidney injury"
        }, 
        "biospec_descr": {
            "textblock": "Serum BNP"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "B-type natriuretic peptide (BNP) is rapidly released by the ventricles of the heart in\n      response to myocardial stretch. This cardiac neurohormone is mostly elevated in patients\n      with fluid overload or myocardium dysfunction. BNP is a very useful and important marker. It\n      can predict mortality and cardiac events in patients in the ICU setting. In stable\n      hemodialysis patients with normal LV function on echocardiography, high BNP levels are\n      likely the result of blood volume expansion and require reduction in postdialysis dry\n      weight.\n\n      In the past, there were many methods to evaluate fluid status. Some are not reliable such as\n      central venous pressure or physical examination. Some are invasive and expensive such as\n      Swan Ganz\u3001PiCCO catheter or bioimpedance device. Nevertheless, About the relationship\n      between BNP and fluid status, a study found a significant relation between\n      bioimpedance-derived body composition (BC) (fluid distribution) parameters and BNP\n      concentrations. This relationship was independent of the cardiac history of the patient and\n      suggests that the natriuretic peptide levels are to some degree modifiable by changing a\n      patient's fluid distribution.\n\n      In this study, the investigators want to observe that if the level of BNP can predict the\n      occurrence of acute kidney injury and the need of renal replacement therapy. Besides, the\n      investigators also want to see if BNP can be a useful and convenient marker to guide\n      adjustment of optimal fluid status and then to improve outcome."
        }, 
        "brief_title": "Exploring the Relationship Among BNP, Fluid Status and Acute Kidney Injury in Critically Ill Patients", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Acute Kidney Injury (Nontraumatic)", 
        "condition_browse": {
            "mesh_term": [
                "Critical Illness", 
                "Acute Kidney Injury", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "B-type natriuretic peptide (BNP) is rapidly released by the ventricles of the heart in\n      response to myocardial stretch. This cardiac neurohormone is mostly elevated in patients\n      with fluid overload or myocardium dysfunction. BNP is a very useful and important marker. It\n      can predict mortality and cardiac events in patients in the ICU setting. In stable\n      hemodialysis patients with normal LV function on echocardiography, high BNP levels are\n      likely the result of blood volume expansion and require reduction in postdialysis dry\n      weight.\n\n      On the other hand, ample recent data have highlighted the role of \ufb02uid accumulation on\n      mortality and non-recovery of kidney function in critically ill patients with acute kidney\n      injury (AKI). In the past, there were many methods to evaluate fluid status. Some are not\n      reliable such as central venous pressure or physical examination. Some are invasive and\n      expensive such as Swan Ganz\u3001PiCCO catheter or bioimpedance device. Nevertheless, About the\n      relationship between BNP and fluid status, a study found a significant relation between\n      bioimpedance-derived body composition (BC) (fluid distribution) parameters and BNP\n      concentrations. This relationship was independent of the cardiac history of the patient and\n      suggests that the natriuretic peptide levels are to some degree modifiable by changing a\n      patient's fluid distribution.\n\n      In this study, we want to observe that if the level of BNP can predict the occurrence of\n      acute kidney injury and the need of renal replacement therapy. Besides, we also want to see\n      if BNP can be a useful and convenient marker to guide adjustment of optimal fluid status and\n      then to improve outcome."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients > 18 y/o in ICU\n\n        Exclusion Criteria:\n\n          -  Acute coronary syndrome\n\n          -  Congestive heart failure history\n\n          -  Clinical pulmonary hypertension with various cause (iPAH, congenital heart disease,\n             CTEPH, COPD with cor pulmonate,\u2026)\n\n          -  Patients with acute pulmonary embolism\n\n          -  Chronic atrial fibrillation,\n\n          -  Respiratory failure with high PEEP (>10 CmH2)\n\n          -  Terminal cancer patients\n\n          -  Patients with Bosmina therapy\n\n          -  Patients received CPR (IHCA or OHCA)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Critically ill patients in intensive care unit(older than 18 y/o)"
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 10, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02095275", 
            "org_study_id": "201111012RIB"
        }, 
        "intervention_browse": {
            "mesh_term": "Natriuretic Peptide, Brain"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "BNP, acute kidney injury, fluid status", 
        "lastchanged_date": "March 20, 2014", 
        "location": {
            "contact": {
                "email": "chouyuhsiang@yahoo.com.tw", 
                "last_name": "yu-hsiang chou, bachelor", 
                "phone": "+886-2-23123456"
            }, 
            "facility": {
                "address": {
                    "city": "Taipei", 
                    "country": "Taiwan", 
                    "zip": "100"
                }, 
                "name": "National Taiwan University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Taiwan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Exploring the Relationship Among Brain Natriuretic Peptide, Fluid Status and Acute Kidney Injury in Critically Ill Patients", 
        "overall_contact": {
            "email": "chouyuhsiang@yahoo.com.tw", 
            "last_name": "yu-hsiang chou, bachelor", 
            "phone": "+886-2-23123456"
        }, 
        "overall_official": {
            "affiliation": "National Taiwan University Hospital", 
            "last_name": "Yu-Hsiang Chou, bachelor", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Taiwan: Department of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from Baseline in serum creatinine level at 3 months", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02095275"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "National Taiwan University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Taiwan University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}